Blog
RSS FeedPosted by Michael Wonder on 04 Mar 2020
When a drug study abruptly ends, volunteers are left to cope
3 March 2020 - A participant might commit months or years to a drug trial, only to see it vanish overnight. ...
Posted by Michael Wonder on 18 Feb 2020
Paying clinical trial participants: legal risks and mitigation strategies
18 February 2020 - Offering remuneration to participants in cancer trials can promote recruitment and retention. ...
Posted by Michael Wonder on 18 Feb 2020
Randomised clinical trials of artificial intelligence
17 February 2020 - As patient data are increasingly captured digitally, the opportunities to deploy artificial intelligence, especially machine learning, ...
Posted by Michael Wonder on 16 Feb 2020
RWE: cost and time savings entice sponsors as pitfalls linger
14 February 2020 - The New England Journal of Medicine published an article earlier this week raising questions about the ...
Posted by Michael Wonder on 20 Jan 2020
Compliance with legal requirement to report clinical trial results on ClinicalTrials.gov: a cohort study
17 January 2020 - Failure to report the results of a clinical trial can distort the evidence base for clinical practice, ...
Posted by Michael Wonder on 14 Jan 2020
Incidental imaging findings in clinical trials
13 January 2020 - Clinical trial end points are outcome measures used to assess the efficacy and safety of an ...
Posted by Michael Wonder on 11 Dec 2019
Strategic need for large prospective studies in different populations
9 December 2019 - Retrospective studies, in which well-characterized individuals with a particular disease are compared with control individuals without the ...
Posted by Michael Wonder on 01 Dec 2019
Adaptive design clinical trials for drugs and biologics guidance for industry
29 November 2019 - This document provides guidance to sponsors and applicants submitting investigational new drug applications, new drug applications, biologics ...
Posted by Michael Wonder on 14 Nov 2019
Watched by Apple
14 November 2019 - After taking over media, social communication, and the consumer economy, the forces of digital innovation are moving ...
Posted by Michael Wonder on 14 Nov 2019
10 year update on study results submitted to ClinicalTrials.gov
14 November 2019 - A decade after ClinicalTrials.gov launched a database for reporting results of clinical trials, the database includes results ...
Posted by Michael Wonder on 31 Oct 2019
Where were the women? Gender parity in clinical trials
30 October 2019 - On October 3, the FDA approved co-formulated tenofovir alafenamide and emtricitabine (F/TAF) for HIV prevention in at-risk ...
Posted by Michael Wonder on 30 Oct 2019
Model assisted designs for early phase clinical trials: simplicity meets superiority
30 October 2019 - Drug development enterprise is struggling because of prohibitively high costs and slow progress. ...
Posted by Michael Wonder on 28 Oct 2019
Where next for randomised controlled trials in global health?
26 October 2019 - The 2019 Nobel Memorial Prize in Economic Sciences was awarded to three economists—Esther Duflo, Abhijit Bannerjee, and ...
Posted by Michael Wonder on 24 Oct 2019
Older patients (still) left out of cancer clinical trials
24 October 2019 - A decade before he became the US Surgeon General, Vivek Murthy, MD, published a 2004 study in ...
Posted by Michael Wonder on 16 Oct 2019
RWE to supplement RCTs: FDA projects continue
15 October 2019 - The US FDA has been working with several different data and research companies to further its ...